Peramivir

Overview

Peramivir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3989402).

API suppliers (1)

Suppliers of Peramivir backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CKD BIO CORPSouth1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Peramivir expires 7 May 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid;trihydrate

Canonical SMILES

CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C.O.O.O

InChIKey

RFUCJKFZFXNIGB-ZBBHRWOZSA-N